Literature DB >> 30093141

Mutation screening of NEK1 in Chinese ALS patients.

Shi Shu1, Xingxing Lei1, Fang Liu2, Bo Cui3, Qing Liu4, Qingyun Ding3, Ming Sheng Liu3, Xiao Guang Li3, Liying Cui5, Xue Zhang6.   

Abstract

NEK1 was recently identified as an amyotrophic lateral sclerosis (ALS) gene through rare variant burden analysis, and its role in ALS in various populations is still unclear. The aim of this study was to determine the frequency and spectrum of NEK1 mutations in an ALS cohort from mainland China. All exons and their flanking intron regions of NEK1 were screened by direct nucleotide sequencing in 377 unrelated ALS patients. These patients were also screened with a massive parallel sequencing gene panel for 24 known ALS genes and C9orf72 hexanucleotide repeat expansion. In totality, we detected 9 variants, comprising 3 novel heterozygous loss-of-function mutations and 6 rare missense variants (MAF < 0.1%) in NEK1. The patient with splice site mutation also carried another probably damaging variant in SOD1. Our study established a NEK1 mutant frequency of 0.8% in Chinese ALS patients, further expanded its spectrum of variants, and highlighted the possibility of coexistence with variants in additional ALS genes in NEK1 loss-of-function carriers.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis (ALS); Loss-of-function mutation; NEK1

Mesh:

Substances:

Year:  2018        PMID: 30093141     DOI: 10.1016/j.neurobiolaging.2018.06.022

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  6 in total

1.  NEK1 Variants in a Cohort of Italian Patients With Amyotrophic Lateral Sclerosis.

Authors:  Nilo Riva; Laura Pozzi; Tommaso Russo; Giovanni Battista Pipitone; Paride Schito; Teuta Domi; Federica Agosta; Angelo Quattrini; Paola Carrera; Massimo Filippi
Journal:  Front Neurosci       Date:  2022-04-14       Impact factor: 5.152

2.  Hand-onset weakness is a common feature of ALS patients with a NEK1 loss-of-function variant.

Authors:  Yu-Shuen Tsai; Kon-Ping Lin; Kang-Yang Jih; Pei-Chien Tsai; Yi-Chu Liao; Yi-Chung Lee
Journal:  Ann Clin Transl Neurol       Date:  2020-05-27       Impact factor: 4.511

Review 3.  The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications.

Authors:  Wenting Guo; Tijs Vandoorne; Jolien Steyaert; Kim A Staats; Ludo Van Den Bosch
Journal:  Brain       Date:  2020-06-01       Impact factor: 13.501

Review 4.  Checking NEKs: Overcoming a Bottleneck in Human Diseases.

Authors:  Andressa Peres de Oliveira; Luidy Kazuo Issayama; Isadora Carolina Betim Pavan; Fernando Riback Silva; Talita Diniz Melo-Hanchuk; Fernando Moreira Simabuco; Jörg Kobarg
Journal:  Molecules       Date:  2020-04-13       Impact factor: 4.411

Review 5.  ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

Authors:  Rita Mejzini; Loren L Flynn; Ianthe L Pitout; Sue Fletcher; Steve D Wilton; P Anthony Akkari
Journal:  Front Neurosci       Date:  2019-12-06       Impact factor: 4.677

Review 6.  Amyotrophic Lateral Sclerosis: Molecular Mechanisms, Biomarkers, and Therapeutic Strategies.

Authors:  Xiaoming Yang; Yanan Ji; Wei Wang; Lilei Zhang; Zehao Chen; Miaomei Yu; Yuntian Shen; Fei Ding; Xiaosong Gu; Hualin Sun
Journal:  Antioxidants (Basel)       Date:  2021-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.